Delivery Order SPE2DB22D1202-SPE2DB25FVFY8
- Not listed
- The Defense Logistics Agency awarded a $1,989.17 delivery order to AmerisourceBergen Drug Corp for the supply of Clindamycin 900 mg/50 ml in dextrose 5% water solution. This competitively awarded, firm fixed price contract was executed on July 18, 2025, with an ultimate completion date of July 21, 2025, and represents a child delivery order under a larger indefinite delivery contract. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,401.76 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Clindamycin 900 mg/50 mL in 5% Dextrose solution. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 23, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, reflecting the company's demonstrated capability to...
- The Defense Logistics Agency awarded a delivery order valued at $1,235.36 to AmerisourceBergen Drug Corp for the supply of Clindamycin 900 mg/50 ml in D5W solution on August 4, 2025, with completion scheduled for August 5, 2025. This non-competitive delivery order represents a firm fixed price transaction executed under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999 and extending...
- The Defense Logistics Agency awarded a $4,916.58 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Clindamycin PH 1% Solution in 60ML units. This non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in that same area. This delivery order is issued under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Clindamycin PH 900 mg/6 ml vials with a ceiling value of $17,867.22. This firm fixed-price delivery order, which is not set-aside, will be performed at the vendor's Corporate Office in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The contract represents a routine pharmaceutical procurement under the defense medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,259.64 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Clindamycin 900 mg/50 ml in Dextrose 5% Water solution. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the competitive nature of the procurement. This delivery...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the provision of Clindamycin 600mg medication, with a total potential value of $3,398.46 and a period of performance through February 12, 2024. This delivery order is issued under a larger, single-award indefinite delivery contract (IDC) held by...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,800.64 delivery order to AmerisourceBergen Drug Corp for 100 units of Clindamycin 150mg on July 29, 2025. This competitive delivery order, issued without set-aside designation, represents a firm fixed price transaction for pharmaceutical procurement supporting federal military and veteran healthcare operations. The award was fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Logistics Agency has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $6,389.20 firm fixed price delivery order contract to provide 4563616605 - CLINDAMYCIN 900 MG/50 ML-D5W 50ML. This delivery order is issued under Amerisourcebergen Drug Corp's $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical to deliver pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. The...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,348.34 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,564,327,564 units of Clindamycin Phosphate 1% Lotion in 60 mL containers. This order is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVFY8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,561.45 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Clindamycin 900 mg/50 mL in 5% dextrose solution (50 mL units). This firm fixed price, competitively awarded delivery order is set to be completed by July 31, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply agreement valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and related entities. As a major healthcare solutions provider, the company maintains an extensive portfolio of federal contracts covering brand-name and generic medications, vaccines, medical devices, and specialized pharmaceutical commodities. This delivery order for Clindamycin—a broad-spectrum antibiotic commonly used in military and federal healthcare settings—exemplifies the routine pharmaceutical supply fulfillment that AmerisourceBergen provides under its DLA prime vendor contract, ensuring continuous availability of essential medications for federal medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/30/25 |